A phase II study of rituximab combined with pirarubicin–cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma
Tsurumi, Hisashi, Hara, Takeshi, Goto, Naoe, Kitagawa, Jun-Ichi, Kanemura, Nobuhiro, Yoshikawa, Takeshi, Kasahara, Senji, Goto, Hideko, Fukuno, Kenji, Yamada, Toshiki, Sawada, Michio, Shimizu, MasahitVolume:
53
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2011.606383
Date:
February, 2012
File:
PDF, 295 KB
english, 2012